Ofev is a medication approved for the treatment of idiopathic pulmonary fibrosis. Its therapeutic purpose is to slow the progression of fibrotic changes in lung tissue. The drug works by inhibiting the activity of the enzyme nicotinamide adenine dinucleotide phosphate oxidase. This inhibition reduces the production of reactive oxygen species that contribute to cellular damage. By decreasing oxidative stress the medication helps preserve alveolar structure and improve respiratory function. The resulting pharmacologic effect is a measurable delay in disease worsening as observed in clinical studies.

Ofev is a prescription medication classified as a tyrosine kinase inhibitor used in the treatment of idiopathic pulmonary fibrosis. It works by targeting specific signaling pathways that drive excessive scarring of lung tissue, thereby slowing disease progression. The active ingredient nintedanib blocks the activity of several kinases involved in fibroblast proliferation and extracellular matrix deposition. By inhibiting these enzymes the drug reduces the formation of new collagen fibers and limits the accumulation of fibrotic lesions in the lungs. This biochemical suppression helps maintain lung function and improves the quality of life for patients with the progressive fibrotic condition. Clinical studies have demonstrated that Ofev provides a measurable delay in disease worsening compared with placebo in the studied patient population.

Ofev is a medication used for certain lung conditions. Common side effects include nausea and diarrhea. Some patients may experience headache or fatigue. Skin reactions such as rash can also occur. Liver enzyme levels may rise which is monitored during treatment. Rarely respiratory symptoms like shortness of breath have been reported. Gastrointestinal upset is a frequent complaint among users. These effects are generally manageable but can impact daily activities.

Ofev may cause nausea, diarrhea, or abdominal discomfort in some individuals. Skin reactions such as rash or itching can occur during treatment. Elevations in liver enzymes have been reported, requiring periodic monitoring. Headache and dizziness are among the less frequent central nervous system effects. Some patients experience fatigue or a general feeling of weakness. Mild flu-like symptoms including fever or sore throat have been documented. Rarely, hypersensitivity reactions such as swelling or breathing difficulties may develop. Long-term use can occasionally lead to edema or changes in kidney function.